Milbemycin Oxime/Lufenuron/Praziquantel
63 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
1
Deaths Reported
160.0%
Death Rate
Active Ingredients
Milbemycin Oxime/Lufenuron/Praziquantel
Administration Routes
OralUnknown
Species Affected
Dog 63
Most Affected Breeds
Retriever - Labrador 9
Shepherd Dog - German 6
Crossbred Canine/dog 5
Beagle 3
Siberian Husky 3
Terrier - Yorkshire 3
Doberman Pinscher 2
Bulldog 2
Spaniel - King Charles Cavalier 2
Mountain Dog - Bernese 2
Most Reported Reactions
Lack of efficacy (endoparasite) - heartworm 23
Vomiting 8
Tremor 7
Seizure NOS 7
Diarrhoea 5
Overdose 3
Weight loss 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Behavioural disorder NOS 3
Lack of efficacy (endoparasite) - tapeworm 2
Walking difficulty 2
Elevated total bilirubin 2
Outcome Breakdown
Ongoing
39 (61.9%)
Recovered/Normal
12 (19.0%)
Outcome Unknown
11 (17.5%)
Died
1 (1.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.